(Q43995472)

28 November 2017

Cellular effects of tamoxifen in primary breast cancer (English)

1 reference

28 November 2017

1 reference

2

I O Ellis

1 reference

28 November 2017

J F Robertson

1

1 reference

28 November 2017

R I Nicholson

3

1 reference

28 November 2017

A Robins

4

1 reference

28 November 2017

J Bell

5

1 reference

28 November 2017

R W Blamey

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 January 1992

1 reference

Breast Cancer Research and Treatment

28 November 2017

1 reference

28 November 2017

20

1 reference

28 November 2017

2

1 reference

28 November 2017

117-123

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01834641

28 November 2017

0 references

cites work

The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1007%2FBF01834641

DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834641

Oestrogen-receptor status and sites of metastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834641

Tumour DNA ploidy as an independent prognostic factor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834641

Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834641

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834641

The pharmacology and clinical uses of tamoxifen

21 January 2018

1 reference

12 December 2020

Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer

1 reference

12 December 2020

Immunocytochemical localization of estrogen receptor in human breast tissue

1 reference

12 December 2020

Prognostic significance of the DNA content of human breast cancer

1 reference

12 December 2020

The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer

1 reference

12 December 2020

Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer

1 reference

12 December 2020

Relationship between primary breast tumor receptor status and patient survival

1 reference

12 December 2020

DNA ploidy and survival in breast cancer patients.

1 reference

12 December 2020

Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen

1 reference

12 December 2020

Carcinoembryonic antigen immunocytochemistry in primary breast cancer

1 reference

12 December 2020

Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy

1 reference

12 December 2020

Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen

1 reference

12 December 2020

A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization

1 reference

12 December 2020

Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course

1 reference

12 December 2020

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

12 December 2020

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer

1 reference

12 December 2020

Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy

1 reference

12 December 2020

Assessment of response to treatment in advanced breast cancer. British Breast Group

1 reference

12 December 2020

Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women

1 reference

12 December 2020

Estrogen receptor assay in primary breast cancer and early recurrence of the disease

1 reference

12 December 2020

Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01834641

1 reference

Dimensions Publication ID

28 November 2017

0 references

1 reference